Compilation in Informatics Essay

essay A+
  • Words: 1491
  • Category: Database

  • Pages: 6

Get Full Essay

Get access to this section to get all the help you need with your essay and educational goals.

Get Access

Mobile devices ( smartphones, tablet computers) have become ubiquitous and subsequently there has been a growth in mobile applications (apps). Concurrently, mobile devices have been integrated into health care practice due to the availability and quality of medical apps. These mobile medical apps offer increased access to clinical references and point-of-care tools.However, there has been little identification of mobile medical apps suitable for the practice of pharmacy.

Pharmacists regularly provide health-related education to patients. The type of education varies from patient to patient and can include information such as drug indication, mechanism of action and purpose of therapy, drug interactions, side effects, proper administration, and disease-specific information. Pharmacists face a number of challenges in providing adequate health-related education to their patients. Information should be tailored to each patient. Topics can be complex and often require continual reinforcement.Appropriate time to devote to health-related education and resources available may be lacking.

Despite these challenges, health-related education provided by a pharmacist has been proven to improve health outcomes. Mobile apps may help alleviate some challenges and provide a new method for pharmacists to provide health-related education. There is limited published information evaluating the utilization of mobile apps as educational tools for patients. Furthermore, desirable features and patient needs for health-related education via mobile technology remain largely unknown. INTRODUCTIONThis study aims to study the use of a mobile app for patient education to (1) quantify patient interest, (2) determine desirable features and (3) determine if a relationship exists between patient variables and interest in an a mobile app for patient education. ePocrates is a very popular medical database suite developed for the Palm Pilot and PalmOS-running compatibles.

It can be downloaded for free by from the ePocrates website. 1. Overview The free drug reference is the #1 mobile drug reference for U. S.

physicians. With it you can search brand, generic, and OTC medicines.Plus, you can customize your homepage for quick access to the features you use most frequently. Check out the “Extras” tab for even more features, like our App Directory that highlights a variety of specialized healthcare apps available for download. 2.

Leadership Team Epocrates is at the forefront of medical technology and committed to providing high-value point-of-care digital solutions to healthcare professionals. Every day, they are challenging themselves and the industry to improve the speed and accessibility of tools and information physicians need to provide safe and effective patient care.At Epocrates, the success is in the value, quality and reliability of the innovative solutions they provide to their broad physician network as well as our ability to bring together stakeholders across the healthcare continuum. 2. 1 Executive Team Rob Cosinuke Epocrates President Heather Gervais Senior Vice President, Commercial Karl Zachar Senior Vice President, Sales Anne Meneghetti Director of Clinical Communications 3.

Privacy Important Update Their ultimate goal is to deliver relevant, useful content to you, our member. Moreover, this updated privacy policy will allow them to provide the nformation necessary for sponsors to better understand and evaluate the effectiveness at targeting caregivers with important educational material. They continue to recognize the sensitivity of this information and value your privacy. 4.

Utilization of Information They use personal information collected through the Services for purposes described in this Policy or disclosed to you in their Services. They may use your information to: * operate and improve Services; * respond to your comments and questions and provide customer service; * provide and deliver products and services you request; send related information, including confirmations, invoices, technical notices, updates, security alerts, and support and administrative messages; * better understand you so that they may tailor messaging and services based on your interests, preferences, needs and specialties; * communicate with you via email, mobile alerts and other messaging services about commercial, non-commercial, sponsored and non-sponsored clinical information, FDA and product safety alerts, new drugs and pharmaceutical studies. send you information via email about products and services offered by Epocrates and their selected partners. 5. Access to Personal Information You may amend any inaccuracies or update your Epocrates profile, including your personal information and email preferences, at any time.

You have the option of correcting, updating, deleting and/or changing contact and demographic information and other information previously provided and stored in our database. If you wish to correct, update, delete or change your information, simply update your profile .We will respond to your request to access within 30 days. You may opt out of any promotional emails at any time by following the unsubscribe instructions in the promotional emails you receive from us, by updating your profile as described below or by sending an email to [email protected]

com. You may opt out of the Epocrates Honors market research program at any time by following the unsubscribe instructions in the invitation emails you receive from us, by updating your profile as described below or by sending an email to [email protected] com. 6.

Content Sources 6. 1 Free Drug & Formulary Information * The information about U. S. FDA-approved medications in Epocrates products is proprietary content developed by the Epocrates Medical Information editors . * This team of physicians and pharmacists continually and thoroughly researches and reviews information from the primary literature, specialty society recommendations, clinical guidelines, manufacturer labeling, standard medical references, and FDA drug safety alerts, and then condenses that information into concise and clinically relevant monographs.We believe this process produces the best available prescribing and drug reference information — content that goes far beyond package inserts, with the inclusion of off-label and pediatric usage.

* Retail pricing data for drugs is sourced from Good Rx. * Formulary status information is provided by our health plan and hospital partners. * The Epocrates drug database is updated at least once per week. 6. 2 MultiCheck / InteractionCheck * Our editors incorporate the latest drug interaction data into the drug interaction checker to help avert potential adverse events.

A recent independent study in The Annals of Pharmacotherapy [2006;40(5):850] compared the performance of eight PDA drug-drug interaction (DDI) programs, including Epocrates’ MultiCheck feature. The study examined both the ability to identify clinically important DDIs (sensitivity) and the ability to avoid alerting users of clinically unimportant DDIs (specificity). Epocrates software performed the best overall and was the only program to score at least 90% on both sensitivity and specificity.Based on these results, the authors concluded that the Epocrates DDI feature is “the most reliable in detecting the clinically relevant interactions studied without the distraction of detecting those of no clinical significance.

” 6. 3 Alternative Medicines * High quality, evidence-based information about complementary and alternative medicines has been developed specifically for Epocrates by an international team of clinicians and researchers. * Subscribers can also check for interactions between drugs and alternative medicines with the drug interaction checker (see above). * The alternative medicines content is updated on an annual basis.

. 4 Diseases * The Epocrates Infectious Disease team reviews the most current specialty guidelines and primary literature, distilling vast amounts of information into concise, yet comprehensive, treatment recommendations for common and uncommon infections. * Recommended medications are linked into the Epocrates drug database. * Quarterly updates ensure that the most current information is available at the point of care. * In a study published in the Annals of Clinical Microbiology and Antimicrobials, Epocrates ID was found to provide treatment recommendations for all patients admitted with a primary or secondary infectious disease diagnosis.

The spectrum of infections included acute meningitis, empyema, endocarditis, osteomyelitis, HIV-related CNS infections, and FUO. 6. 5 Diagnostics * Detailed lab monographs are developed specifically for Epocrates by practicing physicians. * The Lab reference includes both US and SI units. * New lab monographs are added to Epocrates Lab frequently. 7.

News DocAlert messages are carefully selected by Epocrates editors, often in consultation with outside specialists and publishers, and include summaries and expert commentary.Topics include clinical alerts, CME alerts, government safety alerts, and medically relevant tips on practice management. CONCLUSION Given the enormous changes in medicine stemming from the implementation of the Affordable Care Act, the demand for multi-screen information technology to assist healthcare providers has become even more critical. Physicians and other providers have an urgent need for tools and resources that can assist them in meeting more stringent and complex requirements around administrative tracking, economic trajectories of different therapies, and ultimately, patient outcomes.Clinicians clearly endorse the viability of mobile technology to enable rapid access to clinical information and communication among a growing roster of caregivers.

Industry stakeholders such as EHR providers, pharmaceutical companies, technology firms and content owners must now determine how best to leverage this groundswell of behavioral input to inform product development and marketing programs that support providers in successfully embracing these rapidly evolving models of healthcare. REFERENCES: [1] Patrias, K.Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed.

Wendling, DL, technical editor. Bethesda (MD): National Library of Medicine (US); [2] Shah AN, Kantharia BK. Epocrates Dx. Version 3. 14.

San Mateo (CA): Epocrates, Inc. ©2009. [3] Epocrates 2013 Mobile Trends Report. Maximizing Multi-Screen Engagement Among Clinicians. Pp 9-10. [4] http://epocrates1.

custhelp. com/app/answers/detail/a_id/2395/related/1/session/L2F2LzEvdGltZS8xMzc1NDk5NTE5L3NpZC84RFUqUk93bA%3D%3D [5] http://www. epocrates. com/clinical/sources

Get instant access to
all materials

Become a Member